薬剤動態に基づいたPETアミロイドイメージングの参照領域自動設定法の精度検証

A deposit of amyloid β (Aβ) to the central nervous system causes Alzheimer's disease (AD). A periodical evaluation on Aβ, a year, can therefor detect the beginning of AD, and it realizes an effective medical treatment for AD. For quantitative measurement of Aβ deposit is available using PET, an...

Full description

Saved in:
Bibliographic Details
Published inTransactions of Japanese Society for Medical and Biological Engineering Vol. 54Annual; no. 26AM-Abstract; p. S45
Main Authors 永岡, 隆, 岡田, 志麻, 山田, 誉大, 細川, 知紗, 石井, 一成, 木村, 裕一
Format Journal Article
LanguageJapanese
Published 公益社団法人 日本生体医工学会 2016
Japanese Society for Medical and Biological Engineering
Online AccessGet full text
ISSN1347-443X
1881-4379
DOI10.11239/jsmbe.54Annual.S45

Cover

More Information
Summary:A deposit of amyloid β (Aβ) to the central nervous system causes Alzheimer's disease (AD). A periodical evaluation on Aβ, a year, can therefor detect the beginning of AD, and it realizes an effective medical treatment for AD. For quantitative measurement of Aβ deposit is available using PET, and it requires to delineate the cerebellum gray matter as a reference region, when no Aβ deposit occurs physiologically and it has complicated shape. This study aim at proposing automated delineation algorithm based on a kinetics of administered PET tracer for Aβ imaging. The validation using a clinical data presented no significant difference (p < 0.05) between the amount of Aβ deposit using an ordinary manual delineation and the automated method. We can conclude that the algorithm is clinically useful.
ISSN:1347-443X
1881-4379
DOI:10.11239/jsmbe.54Annual.S45